Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17302588rdf:typepubmed:Citationlld:pubmed
pubmed-article:17302588lifeskim:mentionsumls-concept:C0023911lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C0037995lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C0393022lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C0032113lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C1552428lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C1555985lld:lifeskim
pubmed-article:17302588lifeskim:mentionsumls-concept:C1546466lld:lifeskim
pubmed-article:17302588pubmed:issue1lld:pubmed
pubmed-article:17302588pubmed:dateCreated2007-2-16lld:pubmed
pubmed-article:17302588pubmed:abstractTextABO-incompatible living-donor liver transplantation (LDLT) requires a reduction of the anti-ABO antibody titer to <16 before transplantation, which is usually achieved by pre-operative plasma exchange (PE) or double-filtration plasmapheresis. ABO-incompatible transplantations have been performed after a splenectomy with heavy drug immunosupression plus B-cell-specific drugs. Here, we evaluated a pre-transplantation infusion protocol with an anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible LDLT.lld:pubmed
pubmed-article:17302588pubmed:languageenglld:pubmed
pubmed-article:17302588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:citationSubsetIMlld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17302588pubmed:statusMEDLINElld:pubmed
pubmed-article:17302588pubmed:issn0902-0063lld:pubmed
pubmed-article:17302588pubmed:authorpubmed-author:SakuraiHiroyu...lld:pubmed
pubmed-article:17302588pubmed:authorpubmed-author:IsajiShujiSlld:pubmed
pubmed-article:17302588pubmed:authorpubmed-author:UemotoShinjiSlld:pubmed
pubmed-article:17302588pubmed:authorpubmed-author:MizunoShugoSlld:pubmed
pubmed-article:17302588pubmed:authorpubmed-author:UsuiMasanobuMlld:pubmed
pubmed-article:17302588pubmed:issnTypePrintlld:pubmed
pubmed-article:17302588pubmed:volume21lld:pubmed
pubmed-article:17302588pubmed:ownerNLMlld:pubmed
pubmed-article:17302588pubmed:authorsCompleteYlld:pubmed
pubmed-article:17302588pubmed:pagination24-31lld:pubmed
pubmed-article:17302588pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:meshHeadingpubmed-meshheading:17302588...lld:pubmed
pubmed-article:17302588pubmed:articleTitleExperiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.lld:pubmed
pubmed-article:17302588pubmed:affiliationDepartment of Hepatobiliary Pancreatic Surgery, Mie University Hospital, Mie, Japan. m-usui@clin.medic.mie-u.ac.jplld:pubmed
pubmed-article:17302588pubmed:publicationTypeJournal Articlelld:pubmed